Fund HoldingsCaligan Partners LP

Total Portfolio Value
$217.76M
Total Bought
$53.75M
Total Sold
$26.35M
Net Transaction
+$27.40M
Filing Period:
Securities
SharesValue ($K)
Q2 2023
Q3 2023
Change
Q2 2023
Q3 2023
Weight (%)
Change
ALIMERA SCIENCES INC478,77716,835,154+16,356,3771,39852,18923.97%+50,791
INTERCEPT PHARMACEUTICALS INC(Put)1,200,0001,200,000013,27222,248+8,976
STANDARD BIOTOOLS INC8,467,9207,622,413-845,50716,34322,10510.15%+5,762
EVOLUS INC1,760,1361,683,836-76,30012,79615,3907.07%+2,594
EXELIXIS INC(EXEL)910,730910,730017,40419,8999.14%+2,495
ANIKA THERAPEUTICS INC720,2911,081,360+361,06918,71320,1469.25%+1,433
VERRICA PHARMACEUTICALS INC0259,593+259,59301,0100.46%+1,010
Y-MABS THERAPEUTICS INC023,321+23,32101270.06%+127
AGIOS PHARMACEUTICALS INC(AGIO)4,8334,83301371200.05%-17
SOCIETAL CDMO INC1,077,2681,689,768+612,5001,1857940.36%-391
VERONA PHARMA PLC183,064183,06403,8702,9841.37%-886
ADMA BIOLOGICS INC847,513597,513-250,0003,1272,1390.98%-988
EYEPOINT PHARMACEUTICALS INC(EYPT)310,2980-310,2982,7000-2,700
LIQUIDIA CORP(LQDA)9,243,6279,243,627072,56258,60526.91%-13,958
INTERCEPT PHARMACEUTICALS INC1,293,5100-1,293,51014,3060-14,306
Page 1 of 1